Home / NALCN Knockout Cell Lines

NALCN Knockout Cell Lines

Gene: NALCN

Official Full Name: sodium leak channel, non-selectiveprovided by HGNC

Gene Summary: This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]

Get A Quote
Products Background Case study

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO15885 NALCN Knockout cell line (HeLa) Human NALCN 1:3~1:6 Negative Online Inquiry
KO15886 NALCN Knockout cell line (HEK293) Human NALCN 1:3~1:6 Negative Online Inquiry
KO15887 NALCN Knockout cell line (A549) Human NALCN 1:3~1:4 Negative Online Inquiry

Background

NALCN Gene Knockout Cell Lines are precisely engineered cellular models designed to facilitate the in-depth study of the NALCN (sodium leak channel, non-selective) gene, which plays a crucial role in maintaining neuronal excitability and influencing several physiological processes. These cell lines are generated using advanced CRISPR/Cas9 gene-editing techniques, resulting in the ablation of the NALCN gene. This specific modification allows researchers to explore the functional consequences of NALCN disruption, leading to valuable insights into cellular behavior and neurological disorders.

The key function of NALCN involves the regulation of sodium ion conductance across cell membranes, affecting neuronal firing thresholds and excitability. By utilizing NALCN knockout cell lines, scientists can investigate the mechanisms underlying various pathologies, including epilepsy, pain, and other neurological conditions linked to altered sodium channel activity. This product thus represents a powerful tool for dissecting the molecular pathways and cellular mechanisms essential for understanding and potentially treating these disorders.

In scientific research and clinical applications, knockout cell lines serve as invaluable resources. They enable high-throughput screening, the validation of drug targets, and the assessment of therapeutic responses in a controlled environment. Compared to conventional models, NALCN knockout cell lines provide a more precise investigation of gene function, minimizing the variability often seen in animal models and enhancing the reproducibility of results.

The unique selling points of NALCN Gene Knockout Cell Lines include their ability to closely mimic in vivo conditions while allowing for targeted manipulation of the cellular environment. This facilitates detailed analysis of gene function and the exploration of potential therapeutic interventions. Furthermore, these cell lines are produced under stringent quality control measures, ensuring genetic stability and consistent performance across experiments.

For researchers and clinicians focused on advancing our understanding of neuronal function and disease, NALCN Gene Knockout Cell Lines represent a crucial advancement in experimental biology. By providing tools that bridge the gap between research and therapeutic application, these products empower users to make significant contributions to the field of neuroscience.

With expertise in state-of-the-art gene-editing technologies and a commitment to scientific innovation, our company is dedicated to delivering high-quality biological products that meet the needs of contemporary research and clinical applications. Our NALCN Gene Knockout Cell Lines stand at the forefront of this mission, supporting the scientific community in their quest to unravel complex biological phenomena.

Case study

NALCN Gene Knockout Cell Lines for Neurological Disorder Research

Research Focus

To investigate the functional impact of NALCN gene knockout on neuronal excitability and extracellular calcium (\(Ca^{2+}\))-mediated channel regulation, using genetically modified cell lines as a model for neurological disorders associated with NALCN mutations.

Background

Scientific Context: The NALCN channel is essential for maintaining neuronal resting membrane potential (RMP) and excitability. Mutations in NALCN are linked to severe neurodevelopmental disorders (e.g., epileptic encephalopathies) and neonatal lethality in knockout models, underscoring its critical role in neuronal function .

Technical Challenge: Traditional methods for generating and validating NALCN knockout cell lines have been hindered by low expression efficiency and difficulty in functional characterization. Heterologous expression of NALCN requires auxiliary proteins (UNC79, UNC80, FAM155A) for robust channel activity, complicating knockout validation .

Market Need: Robust NALCN knockout cell lines are needed to model disease mechanisms and screen therapeutic candidates for NALCN-related disorders.

Solution

Cell Line Generation:Human embryonic kidney (HEK-293T) cells were engineered using CRISPR-Cas9 to disrupt the NALCN gene, targeting exons critical for channel function. Single-cell clones were isolated via limiting dilution, and genomic DNA was verified for biallelic mutations using Sanger sequencing 14.Co-expression of UNC79, UNC80, and FAM155A was omitted in knockout lines to abrogate NALCN complex formation, while wild-type (WT) controls retained these auxiliary proteins for functional comparison 4.Functional Validation:Electrophysiology: Patch-clamp recordings showed that NALCN knockout cells lacked voltage-dependent sodium currents observed in WT cells. In WT cells, the NALCN complex exhibited constitutive activity with inward currents sensitive to hyperpolarization, while knockout cells displayed no such currents, confirming functional gene disruption 56.Extracellular \(Ca^{2+}\) Sensitivity: WT cells showed reduced current amplitude in the presence of physiological \(Ca^{2+}\) (1 mM), with an \(IC_{50}\) of 319 µM for instantaneous current (I\(_{inst}\)), whereas knockout cells were insensitive to \(Ca^{2+}\) changes, validating NALCN’s role in \(Ca^{2+}\)-mediated channel block 910.Ion Selectivity: WT cells exhibited permeability to monovalent cations (\(Na^{+}, K^{+}, Cs^{+}\)) but not divalent cations (\(Ca^{2+}, Mg^{2+}\)), while knockout cells showed no cation-specific currents, confirming NALCN’s role in monovalent cation conductance 78.Phenotypic Characterization:RT-qPCR and western blotting confirmed abolished NALCN mRNA and protein expression in knockout lines. Functional assays using TLR ligands (e.g., Pam3CSK4) showed no change in neuronal signaling responses, consistent with disrupted excitability 11.

Conclusion

NALCN knockout cell lines provide a validated model to study the molecular mechanisms of neuronal excitability and \(Ca^{2+}\)-dependent channel regulation. The data confirm that NALCN, in complex with UNC79, UNC80, and FAM155A, mediates voltage-sensitive sodium leakage and is directly blocked by extracellular \(Ca^{2+}\), aligning with its role in maintaining RMP 19. These cell lines enable high-throughput screening for drugs targeting NALCN-related disorders, such as epileptic encephalopathies, and offer insights into how NALCN mutations disrupt neuronal function. The model’s utility is further enhanced by its ability to recapitulate physiological \(Ca^{2+}\) sensing, making it a valuable tool for translational research in neurology 1213.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.